Latest EMYRIA (ASX:EMD) News

Page 3

Page 3 of 3

Emyria Accelerates Mental Health Breakthroughs with $2.5M Raise and Leadership Shift

Emyria Advances Mental Health Therapies with $2.5M Capital Boost and New Leadership

Emyria Limited reports strong progress in its MDMA and psilocybin-assisted therapy programs alongside a successful $2.525 million capital raise, positioning the company for expanded mental health treatment services.

Ada Torres

31 Jan 2025

Emyria Elevates Greg Hutchinson to Executive Chair to Accelerate Mental Health Growth

Emyria Limited announces key leadership shifts with Greg Hutchinson stepping up as Executive Chairman and Dr. Michael Winlo transitioning to Chief Scientific Officer, aiming to scale innovative mental health therapies amid growing demand.

Ada Torres

22 Jan 2025